BOC Kenya Profit Jumps 48% as Dividend Climbs to KSh 12.85 - What It Means for Investors

BOC Kenya Plc delivered a strong earnings performance for the year ended December 2025, supported by robust revenue growth, improved cost efficiency, and sustained demand across its core business segments. The industrial and medical gases provider reported profit after tax of KSh 314.0 million, up from KSh 211.6 million, representing a 48.4% year-on-year increase, reflecting a significant strengthening in underlying profitability.

The improved earnings profile has translated into materially higher shareholder returns, with the board recommending a total dividend of KSh 12.85 per share, comprising an interim dividend of KSh 2.50 and a final proposed dividend of KSh 10.35, compared with KSh 8.65 in the prior year. This represents a 48.6% increase in total dividend, aligning closely with earnings growth and reinforcing the company’s progressive payout profile.

Dividend Growth Reflects Strong Earnings Conversion

The dividend increase is underpinned by a sharp rise in earnings per share, which grew to KSh 16.08, from KSh 10.84 in the previous year, highlighting improved earnings quality and efficient capital allocation.

Importantly, the payout reflects strong cash generation, with net cash from operating activities rising to KSh 491.1 million, compared with KSh 168.2 million previously. This improvement in cash flow supports the sustainability of distributions while maintaining balance sheet strength.

Revenue and Profitability: Growth and Cost Discipline Drive Margins

Revenue increased to KSh 1.43 billion, up from KSh 1.20 billion, representing a 19% year-on-year increase, driven by higher demand for medical and industrial gases as well as growth in customer engineering projects.

Profitability expanded at a faster rate than revenue, reflecting the impact of cost discipline. Earnings before investment income and tax rose to KSh 383.7 million, from KSh 222.5 million, while profit before tax increased to KSh 442.7 million, up from KSh 295.5 million.

The company also benefited from a decline in distribution, selling, and administrative expenses, highlighting management’s focus on operational efficiency and margin improvement.

Balance Sheet Strength and Cash Position

BOC Kenya’s balance sheet remained solid, with total assets rising to KSh 2.58 billion, up from KSh 2.25 billion, supported by growth in current assets and operational expansion.

Total equity increased to KSh 2.20 billion, from KSh 1.95 billion, driven by retained earnings growth, while liabilities remained relatively low at KSh 388.7 million, underscoring a conservative capital structure with low leverage.

Cash and cash equivalents increased significantly to KSh 1.05 billion, compared with KSh 676.8 million, reflecting strong liquidity and improved operating performance.

Key Drivers Behind the Performance

The earnings expansion was driven by a combination of revenue growth and improved operational efficiency. Increased demand in healthcare, particularly for medical gases, alongside growth in industrial applications across manufacturing and agriculture, supported top-line expansion. At the same time, deliberate cost-control measures reduced operating expenses, enabling a stronger conversion of revenue into profit.

This combination of volume growth and cost discipline has resulted in a structurally improved margin profile.

Outlook: Expansion Across Healthcare and Industrial Segments

Looking ahead, BOC Kenya is positioning itself for sustained growth by strengthening its leadership in the medical gases segment while expanding its footprint across industrial sectors, including manufacturing, agriculture, and fabrication.

The company’s strategy focuses on broadening its market presence, deepening customer relationships, and maintaining high standards of safety and quality, all of which support long-term resilience and growth.

What This Means for Investors

BOC Kenya’s latest results highlight a business transitioning into a higher growth and higher payout phase, supported by strong demand fundamentals and operational efficiency gains. The near 50% increase in both profit and dividends signals a step-change in earnings capacity and shareholder returns.

However, investors should consider the relatively smaller scale of the business compared to larger NSE-listed firms, which may introduce earnings volatility depending on project cycles and industrial demand trends. Sustaining current growth rates will depend on continued demand expansion and disciplined cost management.

• To analyse BOC Kenya's reported numbers over the last four years, click here, or follow the payout record on its dividend view and the margin trend on its earnings view.

Bottom Line

BOC Kenya has delivered a strong financial performance, with profit and dividend growth closely aligned and supported by improved margins and cash generation. The company’s positioning in both healthcare and industrial segments provides a balanced growth platform, making it an increasingly attractive dividend growth stock within Kenya’s industrial sector, albeit with moderate scale-related risks.